Arcellx, Inc.

Biotechnology company · Redwood City, California, United States

Arcellx, Inc. is a biotechnology company headquartered in Redwood City, California, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Arcellx at a glance

Typebiotechnology company

HeadquartersRedwood City, California, United States

Earliest incorporation on record2014

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1786205

What does Arcellx do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $100 million sold (2023).

Frequently asked questions about Arcellx

Where is Arcellx headquartered?

Arcellx, Inc. is headquartered in Redwood City, California, United States.

What does Arcellx do?

Arcellx, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Arcellx founded?

The earliest incorporation on record for Arcellx, Inc. is in 2014, according to public company registers.

Similar companies

Trellis Bioscience, Inc.Redwood City, California, United States
Coherus Oncology, Inc.Redwood City, California, United States
Revolution Medicines, Inc.Redwood City, California, United States
Adverum Biotechnologies, Inc.Redwood City, California, United States
Genapsys, Inc.Redwood City, California, United States
Proteus Digital Health, Inc.Redwood City, California, United States
Oryn Therapeutics, Inc.Redwood City, California, United States
Antiva Biosciences, Inc.Redwood City, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences